The Anti-Clot Treatment Scale (ACTS) in Clinical Trials: Cross-Cultural Validation in Venous Thromboembolism Patients

Health and Quality of Life Outcomes - United Kingdom
doi 10.1186/1477-7525-10-120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Altered Fibrin Clot Structure/Function in Patients With Idiopathic Venous Thromboembolism and in Their Relatives

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Anticoagulation Treatment Using NOAC in Patients With Venous Thromboembolism

International Journal of Arrhythmia
2016English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Edoxaban for Treatment of Venous Thromboembolism in Patients With Cancer

Thrombosis and Haemostasis
Hematology
2015English

Pcv111 - Clinical Characteristics and Treatment Patterns Among Patients With Venous Thromboembolism Prescribed Anticoagulants in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients With Cancer

The Lancet Oncology
Oncology
2019English

Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients

JAMA Surgery
Surgery
2015English

Recent Advances in the Treatment of Venous Thromboembolism

Japanese Journal of Neurosurgery
SurgeryNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy